Med Biogene Quote - MBI

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.045

Bid

0.045

Ask

0.065

Volume

0.00 Day's Range 0.00

0.045 52 Week Range 0.045

Market Cap

776.565k

Previous Close

0.045

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

17,257,000

Dividend Yield

PE Ratio

-5.88

Earnings Per Share (EPS)

-0

Revenue

Net Profit

-58k

Sector

In Vitro,in Vivo Diagnostics

Industry

In Vitro,in Vivo Diagnostics

Website

www.medbiogene.com/en/406/index.html

Headquarters

Vancouver, British Columbia, Can

Founded

Med Biogene Inc is listed in the In Vitro,in Vivo Diagnostics sector of the TSX Venture Exchange with ticker MBI. The last closing price for Med Biogene was $0.05. Over the last year, Med Biogene shares have traded in a share price range of $ 0.045 to $ 0.045.

Med Biogene currently has 17,257,000 shares outstanding. The market capitalization of Med Biogene is $776,565 . Med Biogene has a price to earnings ratio (PE ratio) of -5.88.

Med Biogene Reports Financial Results for Q1 2014

VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 30, 2014) - Med BioGene Inc. (TSX VENTURE:MBI) today reported its financial results for the three months ended March 31, 2014 (all amounts are in...

Med Biogene Reports Financial Results for Q1 2014

Med Biogene Reports Financial Results for Q1 2014 VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 30, 2014) - Med BioGene Inc. (TSX-VENTURE:MBI) today reported its financial results for the...

Med BioGene Reports Financial Results for 2013

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 30, 2014) - Med BioGene Inc. (TSX VENTURE:MBI) today reported its financial results for the year ended December 31, 2013 (all amounts are in...

Med BioGene Reports Financial Results for 2013

Med BioGene Reports Financial Results for 2013 VANCOUVER, BRITISH COLUMBIA--(Marketwired - Apr 30, 2014) - Med BioGene Inc. (TSX-VENTURE:MBI) today reported its financial results for the year...

Med BioGene Announces Regulatory Approval of GeneFx(R) Lung

VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 24, 2014) - Med BioGene Inc. (TSX VENTURE:MBI) today announced that its commercial partner, Precision Therapeutics, Inc. has received regulatory...

Med BioGene Announces Publication of Data Demonstrating Independent Validation of GeneFx(R) Lung

Med BioGene Announces Publication of Data Demonstrating Independent Validation of GeneFx(R) Lung VANCOUVER, BRITISH COLUMBIA--(Marketwired - Mar 7, 2014) - Med BioGene Inc. (TSX-VENTURE:MBI...

Med BioGene Announces Publication of Data Demonstrating Independent Validation of GeneFx(R) Lung

VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 7, 2014) - Med BioGene Inc. (TSX VENTURE:MBI) today announced the publication in the Journal of Thoracic Oncology of data demonstrating a second...

Med BioGene Provides GeneFx(R) Lung Regulatory Update

Med BioGene Provides GeneFx(R) Lung Regulatory Update VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb 5, 2014) - Med BioGene Inc. (TSX-VENTURE:MBI) today provided an update on the regulatory...

Med BioGene Provides GeneFx(R) Lung Regulatory Update

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 5, 2014) - Med BioGene Inc. (TSX VENTURE:MBI) today provided an update on the regulatory approval process for GeneFx(R) Lung. MBI's commercial...

Period	Open	High	Low
1	0.045	0.045	0.045	CS
4	0.045	0.045	0.045	CS
12	0.045	0.045	0.045	CS
26	0.045	0.045	0.045	CS
52	0.045	0.045	0.045	CS
156	0.045	0.045	0.045	CS
260	0.045	0.045	0.045	CS

MBI - Frequently Asked Questions (FAQ)

What is the current Med Biogene share price?

The current share price of Med Biogene is $ 0.045

How many Med Biogene shares are in issue?

Med Biogene has 17,257,000 shares in issue

What is the market cap of Med Biogene?

The market capitalisation of Med Biogene is CAD 776.57k

What is the 1 year trading range for Med Biogene share price?

Med Biogene has traded in the range of $ 0.045 to $ 0.045 during the past year

What is the PE ratio of Med Biogene?

The price to earnings ratio of Med Biogene is -5.88

What is the reporting currency for Med Biogene?

Med Biogene reports financial results in USD

What is the latest annual profit for Med Biogene?

The latest annual profit of Med Biogene is USD -58k

What is the registered address of Med Biogene?

The registered address for Med Biogene is 598 EAST KENT AVENUE SOUTH, VANCOUVER, VANCOUVER, BRITISH COLUMBIA, V5X 4V6

What is the Med Biogene website address?

The website address for Med Biogene is www.medbiogene.com/en/406/index.html

Which industry sector does Med Biogene operate in?

Med Biogene operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GNFIGenifi Inc	$ 0.015 (200.00%)	4k
GHR.HGolden Harp Resources Inc	$ 0.10 (185.71%)	2.73k
TVC.HThree Valley Copper Corp	$ 0.01 (100.00%)	2k
NICKNickelex Resource Corporation	$ 0.01 (100.00%)	1.1k
GAR.HGreen Arrow Resources Inc	$ 0.045 (80.00%)	1,000
CBAChampion Bear Resources Ltd	$ 0.015 (-62.50%)	101k
NIKL.HGK Resources LTD	$ 0.045 (-50.00%)	1,000
DMDataMetrex AI Limited	$ 0.005 (-50.00%)	3.34M
WWTWater Ways Technologies Inc	$ 0.005 (-50.00%)	106.09k
COOOstrom Climate Solutions Inc	$ 0.05 (-50.00%)	109.5k
QNCQuantum Emotion Corp	$ 0.435 (26.09%)	7.32M
GXUGoviEx Uranium Inc	$ 0.055 (10.00%)	4.68M
FUUF3 Uranium Corp	$ 0.25 (6.38%)	3.64M
AUUAALUULA Composites Inc	$ 0.05 (0.00%)	3.63M
DMDataMetrex AI Limited	$ 0.005 (-50.00%)	3.34M